Adicet Bio Inc. (NASDAQ: ACET) closed the day trading at $1.60 down -5.88% from the previous closing price of $1.70. In other words, the price has decreased by -$0.1000 from its previous closing price. On the day, 1743196 shares were traded. ACET stock price reached its highest trading level at $1.7098 during the session, while it also had its lowest trading level at $1.6000.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
Ratios:
For a better understanding of ACET, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 11.10 and its Current Ratio is at 11.10. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 30 when DUBIN STEVE bought 5,000 shares for $2.40 per share. The transaction valued at 12,000 led to the insider holds 10,900 shares of the business.
GORDON CARL L bought 875,000 shares of ACET for $1,828,750 on Jun 27. The Director now owns 5,685,259 shares after completing the transaction at $2.09 per share. On Jun 27, another insider, ORBIMED ADVISORS LLC, who serves as the Director of the company, bought 875,000 shares for $2.09 each. As a result, the insider paid 1,828,750 and bolstered with 5,685,259 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACET now has a Market Capitalization of 68.91M and an Enterprise Value of -113.91M. Its current Enterprise Value per Revenue stands at 2.14 whereas that against EBITDA is 1.03.
Stock Price History:
Over the past 52 weeks, ACET has reached a high of $21.87, while it has fallen to a 52-week low of $1.62. The 50-Day Moving Average of the stock is 2.3773, while the 200-Day Moving Average is calculated to be 6.4694.
Shares Statistics:
Over the past 3-months, ACET traded about 937.41K shares per day on average, while over the past 10 days, ACET traded about 506.71k shares per day. A total of 42.96M shares are outstanding, with a floating share count of 41.80M. Insiders hold about 0.70% of the company’s shares, while institutions hold 96.07% stake in the company. Shares short for ACET as of Aug 30, 2023 were 2.7M with a Short Ratio of 2.47M, compared to 2.3M on Jul 30, 2023. Therefore, it implies a Short% of Shares Outstanding of 6.26% and a Short% of Float of 8.47%.
Earnings Estimates
Current recommendations for the stock of the company come from 10 analysts. On average, analysts expect EPS of -$0.74 for the current quarter, with a high estimate of -$0.44 and a low estimate of -$0.83, while EPS last year was -$0.53. The consensus estimate for the next quarter is -$0.72, with high estimates of -$0.37 and low estimates of -$0.85.
Analysts are recommending an EPS of between -$2.52 and -$3.16 for the fiscal current year, implying an average EPS of -$2.95. EPS for the following year is -$2.75, with 10 analysts recommending between -$0.45 and -$3.7.